The DOI matches its Crossref record.
GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation
Open accessAbstract
Aromatase inhibitors can be utilized to minimize oestrogen exposure in breast cancer patients undergoing gonadotrophin stimulation. This retrospective-prospective study determined whether using a gonadotrophin-releasing hormone agonist (GnRHa) trigger instead of human chorionic gonadotrophin (HCG) would reduce oestrogen exposure and improve cycle outcomes in aromatase inhibitor cycles. Seventy-four breast cancer patients who desired fertility preservation, with normal ovarian reserve and <45 years of age received letrozole 5 mg/day plus recombinant FSH 150–300 IU/day for ovarian stimulation. Subjects either received HCG 5000–10,000 IU (n = 47) or leuprolide acetate 1 mg (GnRHa, n = 27) as trigger. Oestradiol measurements were repeated 4 days after the trigger and subjects were evaluated for ovarian hyperstimulation syndrome (OHSS). In the GnRHa group, oestradiol concentrations dropped significantly after the trigger than the HCG group (P = 0.013) and there was a lower incidence of OHSS. GnRHa trigger resulted in a higher number and percentage of mature oocytes and a higher number of cryopreserved embryos or oocytes compared with HCG. GnRHa trigger improves outcomes by increasing the yield of mature oocytes and embryos in aromatase inhibitor cycles and also decreases the post-trigger oestradiol exposure as well as OHSS risks in women with breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Loren, A. W., Mangu, P. B., Beck, L. N., Brennan, L., Magdalinski, A. J., Partridge, A. H., Quinn, G., Wallace, W. H., & Oktay, K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.2678 · Cited by 1,611
Self-citation(2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.09.013 · Cited by 753
Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline
Pfeifer, S., Butts, S., Dumesic, D., Fossum, G., Gracia, C., La Barbera, A., Mersereau, J., Odem, R., Paulson, R., Penzias, A., et al. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.08.048 · Cited by 396
Steward, R. G., Lan, L., Shah, A. A., Yeh, J. S., Price, T. M., Goldfarb, J. M., & Muasher, S. J. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.12.026 · Cited by 336
GnRH agonist for triggering of final oocyte maturation: time for a change of practice?
Humaidan, P., Kol, S., Papanikolaou, E., & on behalf of the 'The Copenhagen GnRH Agonist Triggering Workshop Group' (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr008 · Cited by 321
Metadata
- Authors
- Oktay, K., Türkçüoğlu, I., & Rodriguez-Wallberg, K. A.
- Venue
- Reproductive BioMedicine Online
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 20
- Issue
- 6
- Pages
- 783-788
- ISSN
- 1472-6483 (ISSN-L)
- OpenAlex
- W2150267695
- Cited by
- 195
- References
- 0
- FWCI
- 14.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. https://app.cochat.ai/papers/10.1016/j.rbmo.2010.03.004
- The paper
- Oktay, K., Türkçüoğlu, I., & Rodriguez-Wallberg, K. A. (2010). GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2010.03.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.